GSK190937 is a type II platelet-derived growth factor receptor alpha (PDGFRA) human kinase inhibitor with antimalarial activity. GSK190937 can inhibit the formation of hemozoin in the malaria parasite, resulting in the accumulation of free hemoglobin within the malaria parasite. GSK190937 shows IC50 values of 0.22, 0.59 and 0.25 µM against P. falciparum NF54, K1 and Dd2 parasite. GSK190937 shows an IC50 of 25 µM for CHO cells. GSK190937 can be used for research of malaria[1].
Molecular Weight:
427.33
CAS Number:
[2651234-01-2]
Formula:
C22H20Cl2N4O
Target:
Parasite,PDGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
